tiprankstipranks
AbbVie sees FY24 revenue approximately $55B, consensus $54.6B
PremiumThe FlyAbbVie sees FY24 revenue approximately $55B, consensus $54.6B
6d ago
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
PremiumThe Fly
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
6d ago
AbbVie says Q1 results exceeded expectations
PremiumThe Fly
AbbVie says Q1 results exceeded expectations
6d ago
Options Volatility and Implied Earnings Moves Today, April 26, 2024
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, April 26, 2024
7d ago
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
7d ago
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
7d ago
Fake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
PremiumMarket NewsFake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
16d ago
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
PremiumMarket News
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
18d ago
AbbVie presents results from ongoing Phase 3 study of oral atogepant
PremiumThe Fly
AbbVie presents results from ongoing Phase 3 study of oral atogepant
21d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100